Current position:Home >Product >
(5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-ol 2,3-dihydroxybutanedioate (salt)
(5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-ol 2,3-dihydroxybutanedioate (salt)(63813-37-6)
- Name: (5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-ol 2,3-dihydroxybutanedioate (salt)
- Synonyms:Morphinan-8-ol,4,5-epoxy-3-methoxy-17-methyl-, (5a,8a)-,[R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt)
- Molecular Formula:C18 H23 N O3
- Molecular Weight:451.467
- CAS Registry Number:63813-37-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 77473-08-6/3,3’,4,4’-Tetra(t-butyl peroxycarbonate) benzophenone
- 16630-91-4/2-methylheptan-1-al
- 53813-83-5/suriclone
- 111011-00-8/cyclo(phenylalanyl-tryptophyl-lysyl-threonyl-4-(aminomethyl)phenylacetic acid)
- 6487-71-4/N-[(2-bromophenyl)carbamoyl]-2,6-dichlorobenzamide
- 81393-48-8/3-(4-chlorophenyl)-1-methoxy-1-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxa n-2-yl]oxymethyl]urea
- 92389-61-2/platinum(2+) cyclohexane-1,2-diyldiazanide - N-acetylvaline (1:1:2)
- 31613-04-4/3,6-DIMETHYLDIBENZOTHIOPHENE
- 238073-40-0/o-NitrophenylEGTA,tetrapotassiumsalt(NP-EGTA)
- 20055-88-3/cyclohexane-1,3,5-triol
- 128071-39-6/4-[(2-aminoethyl)amino]-1-nitroacridin-9(10H)-one
- 68479-62-9/2-Propenoic acid, polymer with 1,3-bis(2-hydroxyethyl)-5,5-dimethyl-2,4-imidazolidinedione and 4-methylbenzenesulfonic acid
- 52186-09-1/2-benzyl-8-[ethoxy(phenyl)methyl]cyclooctanone
- 113615-71-7/3-amino-1-phenyl-1,4-diazaspiro[5.5]undec-3-en-5-one
- 218155-40-9/4H-Naphtho[2,3-b]pyran-4-one,6-[(O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®3)-O-b-D-glucopyranosyl-(1®6)-b-D-glucopyranosyl)oxy]-5-hydroxy-8-methoxy-2-methyl-
- 1775-97-9/4',6'-DIMETHOXY-2'-HYDROXYCHALCONE
- 4677-60-5/2-[(2-chloro-6-methylphenyl)amino]-N-{2-[(2,6-dimethylphenyl)amino]-2-oxoethyl}-N,N-dimethyl-2-oxoethanaminium bromide
- 7685-94-1/1-Vinyl-1H-pyrrole-2,5-dione
- 99448-97-2/Benzenesulfonic acid, (1,2-dihydro-5-nitro-2-oxo-1-(phenylmethyl)-3H-indol-3-ylidene)hydrazide
- 63813-37-6/(5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-ol 2,3-dihydroxybutanedioate (salt)
- 116079-57-3/2,7-Dioxabicyclo[3.2.1]octan-3-one,6-(acetyloxy)-8-[(1R,2S,8R)-1,2,3,4,5,6,7,8-octahydro-8-hydroxy-1,2,5,5-tetramethyl-2-naphthalenyl]-,(1R,5S,6R,8S)-rel-
- 162558-83-0/9-Octadecenoic acid(9Z)-, (7R)-7,8-dihydro-3,7-dimethyl-6,8-dioxo-6H-2-benzopyran-7-yl ester (9CI)
- 877-65-6/4-TERT-BUTYLBENZYL ALCOHOL
- 108728-68-3/Bloodplatelet-activating factor, lyso-
- 111-16-0/Pimelic acid
- 77191-36-7/Nefiracetam
- 2912-80-3/2,2-Diphenyl-2-ethoxyacetic acid (2-(N-butyl-N-methylamino)ethyl) este r hydrochloride
- 94088-80-9/trimethyl-3-[[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)sulphonyl]amino]propylammonium iodide
- 6943-79-9/4-(2-methylphenyl)butanoic acid
- 63979-88-4/sodium {4-[(4-phenyl-1,3-thiazol-2-yl)sulfamoyl]phenyl}azanide